S100A4 and Zika virus infectious disease: Since S100A4 monocytes/macrophages are the main producers of complement components, we further tested the feasibility of using S100A4 + monocytes as drug targets and found that the S100A4 inhibitor niclosamide could effectively alleviate ZIKV-induced testicular damage and protect the fertility of male mice after ZIKV infection.